Cardiac Insight gets $2.5M for its cardiac and respiratory sensing tech
The company will use the money to accelerate the market penetration of its CardeaScreen product and finalize the development of its wearable sensor technology.
NurseGrid gets $2.5M for its nurse staffing management platform
The company will use the funds to boost its sales and marketing efforts, as well as to further develop the product.
India’s 1mg gets $16M to make India’s health industry more transparent
The company offers two main services: an online pharmacy that makes it easy for users to find a lower-cost drug, and a platform for finding medical labs.
Naya Health raises $4M for its mobile-enabled breast pump
The company's product, The Smart Pump, consists of a set of flanges, a power adapter, two classic bottles with caps, and two nipples with adapters and caps.
Augmedix gets $17M for its Google Glass-powered service for doctors
The company has developed a service that frees doctors from hours of mandated charting and documentation so they can get back to their core responsibility.
ChartSpan gets $3.2M for its personal healthcare records app
The company has also announced plans to bring 300 new healthcare jobs to downtown Greenville, SC, from where it will run its clinical support operations.
BioBeats gets $2.28M for its stress-fighting platform
The company's app takes the data from wearable devices and puts it into a machine-learning platform to deliver insights to healthcare providers or employers.
BeBop Sensors gets money for its smart fabrics tech
The company will use the new capital to advance fabric research and improve fabric production facilities, as well as to produce numerous prototypes.
Brighter raises $21M for its SaaS-enabled dental marketplace
The Series D round was led by General Catalyst Partners with participation from DAG Ventures and existing investors, Mayfield, Benchmark and Tenaya.
ResApp raises $12.5M for its mobile-enabled respiratory disease tool
The funds will be used to expedite an FDA approval for the adult diagnostic test, expand into in-clinic use, and enter European and Asian markets.